Viking Therapeutics, Inc.
VKTXW
VKTXW was delisted on the 8th of April, 2021.
4 hedge funds and large institutions have $731K invested in Viking Therapeutics, Inc. in 2017 Q4 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, 1 reducing their positions, and 0 closing their positions.
167% more capital invested
Capital invested by funds: $274K → $731K (+$457K)
100% more funds holding
Funds holding: 2 → 4 (+2)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
+$75.2K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$6.01K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$233K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $371K | -$233K | -133,500 | -48% |
|
|
PWAM
2
Park West Asset Management
San Francisco,
California
| $242K | – | – | – |
|
|
VF
3
Virtu Financial
New York
| $109K | +$75.2K | +43,100 | New |
|
|
4
UBS Group
Zurich,
Switzerland
| $9K | +$6.01K | +3,448 | New |
|
VKTXW Hedge Fund Activity: Q4 2017 in Review
4 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Viking Therapeutics, Inc. (VKTXW) for Q4 2017, worth a combined $731K — up 167% from $274K a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new VKTXW positions and 0 closed out — a net gain of 2 holders — while 0 added to existing stakes and 1 trimmed.
The largest buyer was Virtu Financial, opening a new position worth an estimated $75.2K. The largest seller was Susquehanna International Group, cutting an estimated $233K.
- 4 institutional investors held Viking Therapeutics, Inc. (VKTXW) as of Q4 2017, up from 2 in Q3 2017.
- Funds reported $731K of Viking Therapeutics, Inc. stock for Q4 2017, up 167% quarter-over-quarter.
- 2 funds opened new Viking Therapeutics, Inc. positions in Q4 2017 and 0 closed out, a net change of +2 holders.
- The largest Viking Therapeutics, Inc. buyer in Q4 2017 was Virtu Financial, an estimated $75.2K added.
- The largest Viking Therapeutics, Inc. seller in Q4 2017 was Susquehanna International Group, an estimated $233K sold.
Based on aggregated 13F filings for Q4 2017.